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Introduction
The interaction of normal epithelial cells with the extracellular
matrix (ECM), is necessary for cell growth and survival (Frisch
and Francis, 1994; Meredith et al., 1993; Meredith et al., 1996).
When epithelial or endothelial cells are detached from the
extracellular matrix they undergo a specialized form of
apoptosis termed anoikis (Frisch and Francis, 1994). Anoikis
is thought to function as a safeguard against cell relocalization
to the wrong locations. During cell transformation a number of
normal cellular functions are altered, including unregulated
proliferation, immortalization and the ability of cells to grow
outside their local environment (metastasize). The ability of
tumor cells to bypass anoikis is believed to have an important
role in metastasis (Bogenrieder and Herlyn, 2003; Frisch and
Screaton, 2001; Hood and Cheresh, 2002; Rytomaa et al.,
2000).
Our understanding of the signaling pathways activated by
cell attachment to the ECM has been advanced by recent
studies (reviewed by DeMali et al., 2003; Ginsberg et al., 2005;
Guo and Giancotti, 2004). Cell adhesion to the extracellular
matrix is mediated through integrins, which are a family of
heterodimeric transmembrane proteins that transmit signals
from outside the cell to inside the cell (DeMali et al., 2003;
Ginsberg et al., 2005; Schwartz and Shattil, 2000). These
signals originate from sites called focal adhesions, clusters of
activated integrins in the cell membrane, which are essential
elements of cell proliferation and survival. The changes
in cellular architecture associated with the formation of
focal adhesions are accompanied by activation of various
signal transduction pathways accompanied by tyrosine
phosphorylation of focal adhesion kinase and paxillin and
activation of cell cycle regulators, resulting in cell proliferation
and survival signals (Assoian, 1997; Bershadsky et al., 2003;
Geiger et al., 2001). Adhesion-dependent signals cooperate
with mitogen-activated pathways whose effects are mediated
by the Rho family of small GTPases (Burridge and
Wennerberg, 2004; Ridley, 2001).
Transformation of cells is characterized by anchorage-
independent cell growth, i.e. growth in soft agar, and activation
of integrins is sufficient for anchorage-independent cell
survival in some cases (Marconi et al., 2004; Meredith et al.,
1993; Zahir et al., 2003). For example, a role for integrins in
cell survival was demonstrated in studies in which function-
blocking integrin antibodies caused epithelial cells to undergo
apoptosis (Frisch and Francis, 1994; Meredith et al., 1996).
Furthermore, MDCK cells expressing a constitutively active
focal adhesion kinase (FAK), which is normally activated in
response to integrin engagement, prevents cells from
undergoing apoptosis when placed in suspension (Frisch et al.,
1996b). These studies, as well as many others, demonstrate that
integrin engagement and subsequent activation of downstream
signaling pathways is essential for survival in epithelial cells.
Myosin II activation is essential for stress fiber and focal
adhesion formation, and is implicated in integrin-mediated
signaling events. In this study we investigated the role of
acto-myosin contractility, and its main regulators, i.e.
myosin light chain kinase (MLCK) and Rho-kinase
(ROCK) in cell survival in normal and Ras-transformed
MCF-10A epithelial cells. Treatment of cells with
pharmacological inhibitors of MLCK (ML-7 and ML-9), or
expression of dominant-negative MLCK, led to apoptosis
in normal and transformed MCF-10A cells. By contrast,
treatment of cells with a ROCK inhibitor (Y-27632) did not
induce apoptosis in these cells. Apoptosis following
inhibition of myosin II activation by MLCK is probably
meditated through the death receptor pathway because
expression of dominant-negative FADD blocked apoptosis.
The apoptosis observed after MLCK inhibition is rescued
by pre-treatment of cells with integrin-activating
antibodies. In addition, this rescue of apoptosis is
dependent on FAK activity, suggesting the participation of
an integrin-dependent signaling pathway. These studies
demonstrate a newly discovered role for MLCK in the
generation of pro-survival signals in both untransformed
and transformed epithelial cells and supports previous
work suggesting distinct cellular roles for Rho-kinase- and
MLCK-dependent regulation of myosin II.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/119/11/2269/DC1
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The actin cytoskeleton and myosin II are key components of
focal adhesion formation and recent studies have shown that
an intact actin cytoskeleton is required for cell survival
(Bharadwaj et al., 2005; Celeste Morley et al., 2003; Cheng et
al., 2004; Kulms et al., 2002; Martin and Leder, 2001; Martin
et al., 2004). In addition, expression of a mutant FAK that
disrupts actin filaments causes apoptosis and loss of adhesion-
independent growth in transformed cells (Westhoff et al.,
2004), further implicating the cytoskeleton in pathways
required for anchorage-independent cell survival. As
described, myosin II is needed for the formation of stress fibers
and focal adhesions. Since adherent cells depend upon
activation of integrins for survival signals, we hypothesized
that myosin II is a target for cell survival regulators. The
formation of focal adhesions and stress fibers is dependent
upon activation of myosin II (Chrzanowska-Wodnicka and
Burridge, 1996). Activation of myosin II through light chain
phosphorylation allows myosin to bind to actin filaments. The
best characterized pathways for phosphorylation of myosin
regulatory light chains are through Rho kinase (ROCK), and
myosin light chain kinase (MLCK) (Kamm and Stull, 2001;
Sorokina and Chernoff, 2005). In addition, ZIP kinase and
DAP kinase have been shown to phosphorylate myosin light
chain and have a role in cell motility and apoptosis (Bialik and
Kimchi, 2004; Kawai et al., 1999; Komatsu and Ikebe, 2004)
Why cells use multiple kinases to phosphorylate and activate
myosin II is still poorly understood, however, the kinases
probably function to regulate diverse biological processes
dependent on myosin II.
Here, we show that inhibition of MLCK induces apoptosis
in both untransformed and transformed MCF-10A cells, in
agreement with recent findings that MLCK induces apoptosis
in vivo (Fazal et al., 2005). Moreover, expression of dominant-
negative FADD prevents apoptosis in these cells, suggesting
that the involvement of the death receptor pathway in apoptosis
is due to MLCK inhibition. We also show that activation of 1
integrin is markedly decreased after inhibition of MLCK or
actin polymerization, and addition of a 1-activating antibody
to adherent epithelial cells protected them from apoptosis, and
this protection correlates with activation of FAK, suggesting
that these agents induce apoptosis through suppression of
integrin-mediated signaling. Interestingly, treatment with Y-
27632, an inhibitor of ROCK, had little effect on cell survival,
suggesting discrete roles for ROCK- and MLCK-dependent
functions in the regulation of myosin II.
Results
The actin cytoskeleton has been recently implicated in cell
survival and we sought to determine the possible role of
myosin II and its regulators in cell survival using a mammary
epithelial cell line, MCF-10A. We first determined if normal
and Ras-transformed MCF-10A cells are susceptible to anoikis
by plating the cells on polyHEMA. Plating of cells on
polyHEMA does not allow cells to adhere to the substratum,
thus inducing apoptosis in cells sensitive to loss of adhesion
signaling. Cells were plated on polyHEMA for 16 hours in 2%
BSA, and assayed for apoptosis using two compounds, annexin
V and propidium iodide (PI), that bind to apoptotic cells. This
allows the cells to be separated into three populations: live,
early apoptotic and late apoptotic. MCF-10A cells were serum
starved in all of the following experiments, and this was
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necessary to prevent cell clumping, which can lead to increased
numbers of live cells because of cell-cell interactions (Rytomaa
et al., 2000). In addition, because many survival pathways
activated in response to cell adhesion are also activated by
growth factors (Howe et al., 1998; Meredith et al., 1993;
Plopper et al., 1995), we attempted to isolate only those
pathways activated as a result of cell adhesion by serum
starvation of the MCF-10A cells. After 72 hours, serum starved
MCF-10A cells began to display signs of apoptosis (data not
shown). All of the assays performed here are well under this
time point, and therefore serum starvation did not have an
impact on the number of apoptotic cells quantified in these
assays. In addition, in all of the assays performed, the untreated
cells have been subject to serum starvation as a control.
The FACS analysis results are summarized in the bar graph
shown in Fig. 1 as the percentage of apoptotic cells.
Approximately 70% of the untransformed MCF-10A cells
undergo apoptosis when plated on polyHEMA for 16 hours
(Fig. 1A). If MCF-10A cells plated on polyHEMA were
cultured for an additional 36 hours, virtually all of the
untransformed MCF-10A cells undergo apoptosis (data not
shown). By contrast, the Ras-transformed MCF-10A cells were
relatively resistant to anoikis when plated on polyHEMA,
exhibiting less than 5% difference in apoptosis compared with
adherent cells after 16 hours. In agreement with previous
studies (Wang et al., 1997; Wang et al., 2002), we found that
untransformed MCF-10A are sensitive to anoikis, whereas
MCF-10A Ras cells are relatively insensitive (Wang et al.,
1997). In addition, we performed the same experiments with
another epithelial cell line, MDCK and MDCK Ras cells, and
found similar results (Fig. 1B). A typical representation of the
FACS results is shown in Fig. 1C. In the plot shown on the left,
untreated cells are found mainly in the lower left quadrant,
meaning there is minimal staining of annexin V and/or PI. In
the plot shown on the right, apoptosis is induced, and the cells
are separated into three populations: live, early apoptotic
(stained with annexin V, lower right quadrant) and late
apoptotic (stained with both annexin V and PI, upper right
quadrant). The results above support previous studies
demonstrating that normal epithelial cells require adhesion to
the ECM for survival, whereas transformed cells are resistant
to anoikis following the loss of cell attachment (Frisch and
Francis, 1994; Meredith et al., 1993; Rytomaa et al., 2000).
Recent studies have underscored the importance of an intact
actin cytoskeleton for cell survival in MCF-10A and HeLa
cells, demonstrating that disruption of actin filaments by
treatment with actin polymerization inhibitors (latrunculin A
and B) or by actin filament disruption (cytochalasin B and D)
induces apoptosis (Cheng et al., 2004; Kulms et al., 2002;
Martin and Leder, 2001; Martin et al., 2004; Rubtsova et al.,
1998). Similar experiments were repeated in this study to
confirm these results in our cell lines. Apoptosis of MCF-10A
and MCF-10A Ras was observed after treatments with
latrunculin A (data not shown). To determine whether cells
were undergoing apoptosis as a result of detachment from the
substrate following disruption of the actin cytoskeleton, the
activation state of caspases was examined in adherent cells.
Untransformed and Ras-transformed MCF-10A cells were
grown on coverslips and treated with 5 M latrunculin A. The
cells were then fixed and permeabilized, and stained with
phalloidin, Topro-3 and an anti-caspase-3 antibody that
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specifically recognizes the active form
of caspase-3. MCF-10A and MCF-10A
Ras cells treated with latrunculin A
exhibit a complete disruption of actin
filaments and activation of caspase-3
(supplementary material Fig. S1A).
Staining with Topro-3, a nuclear
stain, demonstrates the chromatin
condensation of MCF-10A cells,
another hallmark of apoptosis
(supplementary material Fig. S1A).
These experiments support previous
studies suggesting that actin
polymerization and/or an intact actin
cytoskeleton are needed for epithelial
cell survival, and these effects are
observed in adherent cells.
Inhibition of MLCK induces
apoptosis in adherent cells
Inhibitors of MLCK and ROCK were
then used to determine the role myosin
II activation might have in cell
survival. Previous studies in epithelial
cells suggesting a pro-survival role for
the actin cytoskeleton (Kulms et al.,
2002; Martin and Leder, 2001; Martin
et al., 2004; Rubtsova et al., 1998),
led us to the question of whether
inhibition of myosin II light chain
phosphorylation would induce
apoptosis in epithelial cells. Both
untransformed and Ras-transformed
MCF-10A cells were treated with ML-
7, ML-9 and Y-27632. ML-7 and ML-
9 inhibit the catalytic activity of
MLCK (Saitoh et al., 1987) and Y-
27632 inhibits ROCK activity
(Narumiya et al., 2000). The number
of apoptotic cells was determined
using FACS analysis as described
above. Briefly, the cells were treated
with MLCK and ROCK inhibitors for
16 hours, and cells were then
collected, stained with annexin V
FITC and PI and sorted by FACS
analysis. As shown in Fig. 1, both
MCF-10A and MCF-10A Ras undergo
apoptosis in response to MLCK
inhibition. After 16 hours ~50-60% of
normal and transformed MCF-10A
cells undergo apoptosis. This effect of
MLCK inhibitors on apoptosis is time-
and dosage-dependent (data not
shown), and the concentration and duration of the inhibitor
treatment used in this investigation was based on our previous
studies of the effects of time and dosage. To ensure that the
above results are not specific to MCF-10A cells, we then
tested another epithelial cell line, MDCK, and similar results
were obtained. However, MCF-10A and MCF-10A Ras cells
treated with the ROCK inhibitor Y-27632 did not display
significant apoptosis. Again, similar results were found in
MDCK and MDCK Ras cells (Fig. 1B). A control to test for
decrease in myosin light chain phosphorylation after treatment
with inhibitors for 1 hour is demonstrated by western blotting
in Fig. S1B in the supplementary material.
As with the treatment of latrunculin A, in order to determine
whether cells were detaching from the substrate following
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Fig. 1. FACS analysis of cells treated with MLCK and ROCK inhibitors. (A) Percentage
apoptosis of untransformed and Ras-transformed MCF-10A cells grown on polyHEMA or
treated with inhibitors of MLCK or ROCK. Cells were plated on polyHEMA and adherent
cells were treated with ML-7 (40 M), ML-9 (40 M) and Y-27632 (30 M) for 16 hours.
Cells were then collected, stained with annexin V FITC and propidium iodide and subjected to
FACS analysis. Results presented are the mean ± s.e.m. of at least three experiments.
(B) Percentage apoptosis of MDCK and MDCK Ras cells grown on polyHEMA or treated
with inhibitors of MLCK or ROCK. (C) Example plot of untreated MCF-10A cells, and MCF-
10A cells treated with ML-7.
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inhibition of MLCK, and then undergoing apoptosis owing to
loss of MLCK activity, adherent cells were monitored for
signs of apoptosis. Untransformed and Ras-transformed MCF-
10A cells were grown on coverslips and treated with MLCK
and ROCK inhibitors. The cells were then fixed and
permeabilized, and stained with phalloidin, Topro-3 and an
anti-caspase-3 antibody that specifically recognizes the active
form of this caspase. Figs 2 and 3 show activation of caspase-
3 in adherent cells treated with the MLCK inhibitors ML-9 or
ML-7 after 16 hours of treatment. In agreement with the FACS
analyses, cells treated with 30 M Y-27632 for 16 hours
exhibited little or no activation of caspase-3 above untreated
cells (Fig. 4).
It is noteworthy that the morphology of cells treated with
MLCK or actin filament polymerization inhibitors seems to
disrupt cell-cell adhesions, whereas ROCK inhibition does not.
Whether this is a result of apoptosis (cell rounding) or a factor
contributing to apoptosis is unknown at this stage. These
results demonstrate that inhibition of MLCK causes apoptosis
in both normal and transformed epithelial cells, suggesting a
role for MLCK in cell survival. Furthermore, these results
support and extend previous studies implicating distinct
cellular functions for MLCK and ROCK (Totsukawa et al.,
2004; Totsukawa et al., 2000).
Expression of dominant-negative MLCK induces
apoptosis in untransformed and Ras-transformed
MCF-10A cells
The above data demonstrate that treatment of cells with
pharmacological agents that inhibit myosin light chain kinase
induces apoptosis. In order to provide additional evidence
supporting a role for MLCK in cell survival, MCF-10A cells
were transiently transfected with wild-type and kinase-dead
non-muscle and smooth muscle (short) MLCK. As shown in
Fig. 5, cells transfected with the dominant-negative proteins
undergo apoptosis, visualized by Topro-3 staining. Table 1
displays the percentage of apoptotic cells in the total cell
population, as well as the percentage of apoptotic cells that
were FLAG tagged. Table 2 summarizes the percentage of
apoptosis in transfected cells. The numbers of apoptotic cells
were counted by scoring cells for
chromatin condensation at 16, 24, 36
and 48 hours. For each time point,
three independent sets of transfections
were carried out and random fields,
totaling 100 cells were counted. The
total number of transfected cells was
between 30% and 40%. As shown, the
number of apoptotic cells transfected
with kinase-dead MLCK increases
with time, and by 72 hours, there are
no detectable transfected cells (Table
2). We attribute the inability to detect
transfected cells on the coverslips after
72 hours to the apoptosis observed
after expression of a kinase-dead
MLCK, resulting in loss of adhesion.
As a control, wild-type smooth muscle
MLCK was transfected into MCF-10A
cells, and these transfected cells
displayed 5-10% apoptosis (Table 1),
the same as control untransfected cells.
Owing to the fact that the cells
underwent apoptosis within 72 hours,
stable cell lines could not be produced,
and the state of myosin light chain
phosphorylation could not be tested.
These studies further indicate that
MLCK has a role in the survival of
both untransformed and transformed
epithelial cells.
Apoptosis induced by inhibition of
MLCK is suppressed by
expression of dominant-negative
FADD
Next, we investigated the apoptotic
Journal of Cell Science 119 (11)
Fig. 2. Inhibition of MLCK by ML-7 induces activation of caspase-3 in adherent MCF-10A
and MCF-10A Ras-transformed cells. Cells were grown on coverslips and treated with ML-7
(40 M) for 16 hours. Cells were then fixed with 3% paraformaldehyde, then permeabilized
and stained with Topro-3, anti caspase-3 (Cell Signaling) and anti-actin (Rhodamine-
phalloidin).
Table 1. Percentage apoptosis after transfection of wild-
type MLCK
MCF10A Parental NM MCF10A Parental SM 
MLCK wt MLCK wt
16 hours 7±2 6±1
24 hours 7±2 8±2
36 hours 8±2 8±2
48 hours 10±2 9±1
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pathway that is activated in response to MLCK inhibition.
Apoptosis can be initiated through an intrinsic or extrinsic
pathway (reviewed by Fridman and Lowe, 2003). The intrinsic
pathway is characterized by mitochondrial release of
cytochrome c, whereas the extrinsic pathway is activated
through transmembrane death receptors. Overexpression of a
dominant-negative component of the CD95/Fas death receptor,
FADD, was shown to inhibit anoikis in MDCK cells (Frisch,
1999; Frisch et al., 1996a). We used this dominant-negative
FADD vector and stably transfected MCF-10A cells. FADD
initiates caspase activation by recruiting caspase-8 to the cell
membrane, resulting in self-activation of caspase-8, and
subsequent activation of downstream caspases. A dominant-
negative FADD prevents activation of caspase-8 when
apoptosis is initiated through the death receptor pathway,
resulting in protection from apoptosis (Zhang et al., 1998). As
shown in Fig. 6, cells transfected with DN FADD are protected
from apoptosis when treated with ML-7 or ML-9. Stably
transfected MCF-10A cells were tested in an anoikis assay, and
we found that they were resistant to anoikis (Fig. 6), similar to
Fig. 3. Inhibition of MLCK by
ML-9 induces activation of
caspase-3 in adherent MCF-
10A and MCF-10A Ras-
transformed cells. Cells were
grown on coverslips and treated
with ML-9 (40 M) for 16
hours. Cells were then fixed
with 3% paraformaldehyde,
permeabilized and stained with
Topro-3, anti caspase-3 (Cell
Signaling) and anti-actin
(Rhodamine-phalloidin).
Table 2. Percentage apoptosis after transfection of DN MLCK
% Apoptosis of total cells % Apoptosis of transfected cells
MCF-10A Parental NM MCF-10A Parental SM MCF-10A Parental NM MCF-10A Parental SM 
MLCK KD MLCK KD MLCK KD MLCK KD 
16 hours 39±5 30±6 79±6 83±6
24 hours 39±5 33±7 87±5 85±5
36 hours 49±8 38±5 90±5 88±6
48 hours 56±6 47±5 92±8 96±4
MCF-10A Ras NM MCF-10A Ras SM MCF-10A Ras NM MCF-10A Ras SM 
MLCK KD MLCK KD MLCK KD MLCK KD 
16 hours 25±4 27±5 66±7 69±4
24 hours 41±6 30±8 80±8 78±6
36 hours 49±6 38±4 94±6 85±5
48 hours 53±7 43±3 93±5 94±6
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the results found previously in MDCK cells expressing DN
FADD (Frisch, 1999). DN FADD expressing MCF-10A cells
were characterized by the expression of truncated FADD
protein (data not shown). The MCF-10A cells expressing
DN FADD also exhibited a different morphology from
untransfected cells, with decreased cell-cell contacts, and a
more fibroblast-like morphology. However, stably transfected
MCF-10A Ras cells did not appear to have a different
morphology to untransfected MCF-10A Ras cells. Thus, it
appears that apoptosis induced following inhibition of MLCK
is mediated through the death receptor pathway, and this
apoptosis is not dependent on expression of the Fas ligand,
which was observed by western blot after treatment of MCF-
10A cells (data not shown).
Inhibition of MLCK results in decreased activation of
1 integrin in untransformed and Ras-transformed
MCF-10A cells
Integrins and soluble growth factors cooperate to promote
cellular response to ECM components to generate signals
required for cell survival and proliferation (DeMali et al., 2003;
Geiger et al., 2001). To determine if activation of integrins
might be involved in mediating the apoptotic response of cells
to inhibition of actin polymerization, or MLCK, we first
analyzed the active state of integrins using a 1 integrin
antibody that specifically recognizes the integrin is in its active
state. MCF-10A and MCF-10A Ras cells were treated with
MLCK inhibitors ML-7 and ML-9, the actin polymerization
inhibitor latrunculin A, and a myosin II specific inhibitor,
blebbistatin (BB) (Kovacs et al., 2004) for 2 hours, before any
caspase activation is detected. Blebbistatin was used in this
experiment to determine if the results observed with MLCK
inhibitors are consistent with the results of inhibition of myosin
II activity. MCF-10A and MCF-10A Ras cells were stained
with a 1-integrin antibody that recognizes 1 integrin in its
active state called HUTS21 (Fig. 7). This antibody was used
in a similar assay by Vial and colleagues to demonstrate
suppression of 1 signaling by Fra-1 (Vial et al., 2003). All
treatments resulted in a significant decrease in levels of active
1 integrin, supporting a role for integrin activity downstream
of MLCK-dependent pathways. MCF-10A and MCF-10A Ras
cells were also treated with the ROCK inhibitor, Y-27632, and
no significant decrease in active 1 integrin was detected,
although the distribution of active 1 integrin was different
(data not shown).
Interestingly, the localization of active 1 integrin in treated
cells changes, from cortical regions and at the ends of stress
fibers to a more perinuclear and cytoplasmic distribution.
Furthermore, to demonstrate the decreased activity levels of 1
integrin was not due to a decrease in the amount of total integrin
protein on the cell surface, cells were stained with a 1-integrin
antibody that recognizes total 1 integrin (supplementary
Journal of Cell Science 119 (11)
Fig. 4. Inhibition of ROCK by
Y-27632 does not activate
caspase-3 in adherent MCF-
10A and MCF-10A Ras-
transformed cells. Cells were
grown on coverslips and
treated with Y27632 (30 M),
for 16 hours. Cells were then
fixed with 3%
paraformaldehyde,
permeabilized and stained with
Topro-3, anti caspase-3 (Cell
Signaling) and anti-actin
(Rhodamine-phalloidin).
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material Fig. S2) and a western blot was performed after 2 hours
of treatment (Fig. 7C). These results suggest that inhibition of
actin polymerization, myosin II phosphorylation, or MLCK is
associated with the inactivation of integrin 1 in untransformed
and Ras-transformed MCF-10A cells.
A 1-integrin-activating antibody can protect
untransformed and Ras-transformed MCF-10A cells
from apoptosis by inhibition of MLCK or disruption of
actin filaments through a FAK-dependent mechanism
Previous studies have shown that HMT-3522 mammary
epithelial cell lines are dependent upon activation of 1 integrin
for survival (Weaver et al., 1996). The results presented above
(Fig. 7) suggested that 1 integrin inactivation could be a
prerequisite for inducing apoptosis via inhibition of myosin
activation through MLCK or actin filament polymerization. To
test this hypothesis, cells were treated with a 1-integrin-
activating antibody before addition of latrunculin A, ML-7,
and ML-9, and tested for rescue from apoptosis following
inhibition of MLCK, myosin II and actin filament
polymerization. Accordingly, a 1-integrin-activating antibody,
9EG7, which can maintain activation of 1 integrin, was added
to cells before drug treatment. Untransformed and Ras-
transformed MCF-10A cells were grown in the presence of 20
g/ml 9EG7 as described in the Materials and Methods. Cells
were then treated with the inhibitors above, stained with
Annexin V FITC and propidium iodide and subjected to FACS
analysis. As shown in Fig. 8, both untransformed and
transformed MCF-10A cells are protected from apoptosis by
addition of 9EG7; however, there appears to be a greater
protective effect with 9EG7 in the MCF-10A parental cell
lines.
To address the issue of which signaling pathways are
involved in MCF-10A cell rescue of apoptosis by 9EG7, we
investigated the components downstream of integrin activation.
Since overexpression of a constitutively active FAK can rescue
epithelial cells from anoikis (Frisch et al., 1996b), we
investigated whether FAK had a role in the rescue of apoptosis
by 9EG7. Cell extracts were made of serum-starved MCF-10A
cells pre-treated for 24 hours with 9EG7 and subsequently
treated with blebbistatin, latrunculin A and ML-7 for 1 hour.
As shown in Fig. 8C, cells treated with inhibitors of MLCK,
actin filament polymerization or myosin II alone for 1 hour
display a decrease in phosphorylation of FAK. However,
suppression of phospho-FAK was not observed in cells pre-
treated with the 1-integrin-activating antibody, 9EG7 (Fig.
8C). In addition, the total FAK levels are unchanged (Fig. 8C).
These results suggest that activation of myosin II through
MLCK is required for the generation of anti-apoptotic
signals by activating integrin-dependent pathways in both
Fig. 5. Expression of kinase-
dead MLCK activates caspase-
3 in MCF-10A cells.
(A) Normal and Ras-
transformed MCF10A cells
transfected with a kinase-dead
MLCK undergo apoptosis.
Cells were grown on coverslips,
transfected with a FLAG-
tagged kinase-dead non-muscle
(NM MLCK KD) or kinase-
dead smooth muscle MLCK
(SM MLCK KD) using
Lipofectamine 2000
(Invitrogen). Cells were grown
for 24 hours, fixed in 3%
paraformaldehyde and stained
with anti-FLAG polyclonal
antibody (Sigma), Topro-3 and
anti-actin (Rhodamine-
phalloidin).Jo
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untransformed and Ras-transformed cells. Furthermore,
addition of an 3- or 5-integrin-blocking antibody, which does
not allow activation of either 3 or 5 integrins, causes MCF-
10A Ras cells to undergo apoptosis (data not shown). This
effect was specific for 3 and 5 integrin subunits because
addition of blocking antibodies for 2 or 6 subunits had no
effect (data not shown). Both 3 and 5 integrins can bind with
1 integrin, supporting the above data that MCF-10A Ras cells
are rescued from apoptosis through activation of 1 integrin.
Discussion
Based on the hypothesis by Burridge and others, activation of
acto-myosin contractility is an indispensable step in the process
of formation of focal adhesions (Chrzanowska-Wodnicka and
Burridge, 1996; Delanoe-Ayari et al., 2004; DeMali et al.,
2003; Helfman et al., 1999). In this study we investigated the
role of acto-myosin contractility and its main regulators, i.e.
MLCK and Rho-kinase. We found that untransformed and Ras-
transformed epithelial cells are dependent upon MLCK activity
for survival, and this survival is mediated through integrin
activation. This study indicates that survival signals in both
untransformed and transformed cells are dependent on MLCK
activity, and not ROCK activity. Adhesion of untransformed
cells to matrix results in cytoskeletal remodeling, including
myosin II activation via MLCK resulting in integrin clustering
and adhesion-dependent signaling (Fig. 9, model 1).
Interestingly, our studies also demonstrated that Ras-
transformed cells are also dependent on MLCK and integrin
activation for survival signals (Fig. 9). Thus, although one
might expect Ras-transformed cells to bypass the requirement
for cytoskeletal remodeling and acto-myosin contractility for
survival signals, our data demonstrate that acto-myosin
contractility under the control of MLCK is required for cell
survival (Fig. 9, model 2).
Interestingly, several groups have proposed that an autocrine
loop exists in transformed cells involving constitutive
activation of integrins. Lee et al. (Lee et al., 2004) have shown
that transformed mammary epithelial cells can secrete a protein
that associates with integrins and promotes cell adhesion and
cell survival. In addition, Weaver and colleagues, investigated
breast tumors that express large amounts of laminin-5, a matrix
protein (Weaver et al., 1996). Their findings demonstrate that
an autocrine LM-5 mediates anchorage-independent survival
in breast tumors through ligation of a particular integrin. This
integrin mediates tumor survival through activation of basal
and epidermal-growth-factor-induced RAC activity, and RAC
mediates tumor survival (Zahir et al., 2003). These studies
support the idea that a transformed cell escapes apoptosis
through constitutive activation of integrins, and therefore
adhesion-mediated signaling. As shown in Fig. 9, we propose
a model (model 2) in which Ras-transformed cells could target
upstream regulators of myosin II, i.e. MLCK, leading to
formation of integrin-dependent signaling complexes and
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Fig. 7. Decreased activation of 1 integrin in MCF10A cells after
inhibition of myosin II, actin polymerization and MLCK.
Untransformed MCF-10A (A) or Ras-transformed MCF-10A cells
(B) were treated with MLCK, myosin II and actin polymerization
inhibitors, as indicated. Cells were grown on coverslips and treated
for 2 hours, then fixed in 3% paraformaldehyde and stained with an
anti-1-integrin antibody (clone HUTS-21), which recognizes
integrins in their active state, Topro-3 and anti-actin (Rhodamine-
phalloidin). (C) Western blot showing level of 1 integrin after 2
hours of treatment with inhibitors.
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Fig. 7. See previous page for legend.
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initiation of survival signals even in the absence of cell
adhesion. This would allow a transformed cell to bypass the
requirement for cell adhesion.
Several studies have indicated that MLCK or ROCK have a
pro-apoptotic role in the apoptotic program (Bisson et al.,
2003; Coleman et al., 2001; Jin et al., 2001; Petrache et al.,
2003; Petrache et al., 2001; Sebbagh et al., 2001). MLCK and
ROCK were both found to be cleaved and in a constitutively
active state when cells were treated with tumor necrosis factor
(TNF), an inducer of apoptosis (Petrache et al., 2003; Petrache
et al., 2001). The constitutively active MLCK or ROCK is
thought to contribute to membrane blebbing observed during
late apoptosis (Mills et al., 1998; Song et al., 2002). In addition,
Gallagher and colleagues found that inhibition of MLCK
decreased apoptosis in TNF-treated cells in the early stages of
apoptosis (Jin et al., 2001). Myosin light chain phosphorylation
status was found to correlate with localization of TNFR to the
cell membrane, linking myosin II activation to TNF-induced
apoptosis. These results are not necessarily in conflict with our
data demonstrating a requirement for MLCK activity for cell
survival. Myosin II has multiple functions within the cell, and
our studies demonstrate a previously uncharacterized role for
myosin II and myosin light chain kinase in preventing
apoptosis in cells. It is possible that activation of actomyosin
contractility is needed in pathways that both prevent and
facilitate the apoptotic program. An adherent cell may depend
upon activation of actomyosin contractility for survival, and
once apoptosis is initiated, these same proteins contribute to
the new cell program. In addition, a recent study by de
Lanerolle and colleagues found that inhibition of MLCK
induces apoptosis in mammary cells in vivo (Fazal et al., 2005).
Here, we have shown that inhibition of ROCK has no effect
on cell survival, but inhibition of MLCK induces apoptosis.
There are several possible explanations for these observations.
One scenario is that ROCK inhibition by Y-27632 blocks
myosin light chain phosphorylation (as shown in
Journal of Cell Science 119 (11)
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supplementary material Fig. S1B), but other targets
downstream of ROCK remain unaffected, leading to cell
survival, whereas the effects of MLCK inhibition are on
myosin light chain phosphorylation alone. This is probably not
the case, because the inhibition of ROCK catalytic activity by
Y-27632 should block all ROCK activity. However, the
possibility remains that unknown functions or targets of ROCK
exist. A second explanation for the results presented here is
that the pharmacological agents used are affecting other
unknown pathways. We have attempted to use control
experiments to ensure that this has not occurred.
The observation made here that ROCK is unnecessary for
MCF-10A cell survival, and that MLCK has a role in the
maintenance of epithelial cells, supports the view that these
two kinases have distinct functions within the cell. It was
previously shown that ROCK and MLCK have distinct
functions in the spatial regulation of myosin light chain
phosphorylation in 3T3 fibroblasts, with MLCK responsible
for the formation of stress fibers at the periphery of the cell and
ROCK necessary for the assembly of stress fibers in the center
of the cell (Totsukawa et al., 2000). Further evidence for the
separate roles of MLCK and ROCK shows that during cell
migration MLCK and ROCK have specialized functions within
the cell, with MLCK necessary for membrane ruffling, and
ROCK discovered to be more important for efficient cell
migration (Totsukawa et al., 2004). Recently we reported that
activation of the ERK cascade by Ras was dependent on
MLCK and not ROCK (Helfman and Pawlak, 2005). ROCK
activation is also required for survival in some cell types (Li et
al., 2002), indicating that the effects seen here are cell-type
specific.
We show that activation of 1 integrin is markedly decreased
in MCF-10A and MCF-10A Ras cells after treatment with
agents that inhibit myosin, myosin light chain kinase and actin
polymerization (Fig. 9). Furthermore, addition of a 1-
activating antibody to epithelial cells protected them from
apoptosis through a FAK-dependent mechanism, suggesting
that these agents induce apoptosis through suppression of
integrin-mediated signaling. However, the activating antibody
shows a greater protective effect on MCF-10A parental cells
compared with the Ras-transformed MCF-10A cells treated
with MLCK inhibitors (Fig. 8), suggesting that the Ras-
transformed cells may be undergoing apoptosis in response to
more than one cellular cue. MCF-10A Ras cells were tested for
their dependence on active integrins for survival, and we found
that blocking 3 or 5 integrin using specific antibodies induces
significant apoptosis in MCF-10A Ras cells (data not shown).
This supports the notion that Ras-transformed cells are
dependent on active integrins for survival, and also supports
the model in Fig. 9 showing that regulation of myosin II
downstream of Ras in transformed cells could generate survival
signals.
Although both ROCK and MLCK are implicated in the
formation of integrin-containing adhesive structures, further
studies will be required to determine how these kinases
differentially mediate integrin-dependent function. Finally, the
signaling pathways involved in apoptosis through the
suppression of integrin activation remain to be determined.
In conclusion, we have shown that disruption of actin
filaments or inhibition of MLCK in untransformed and Ras-
transformed MDCK or MCF-10A cells induces apoptosis. Our
results are supported by studies demonstrating that inhibition
of MLCK activity induces apoptosis in vivo (Fazal et al.,
2005). Apoptosis following inhibition of MLCK is mediated
through the death receptor pathway because expression of
dominant-negative FADD, or treatment of cells with zIETD-
FMK (data not shown) – both inhibitors of caspase-8 activation
– blocked apoptosis. In addition, apoptosis induced by
disruption of actin filaments and inhibition of MLCK is
probably due to inhibition of integrin-mediated signaling
because treatment of cells with integrin-activating antibodies
prevented apoptosis. These studies also demonstrate that
MLCK, but not ROCK, has an essential role in the survival of
both untransformed and transformed epithelial cells and
indicate distinct cellular roles for Rho-kinase- and MLCK-
dependent functions involving the regulation of cell survival.
Materials and Methods
Antibodies and reagents
Cleaved caspase-3 polyclonal antibody was purchased from Cell Signaling
(Beverly, MA). Trevigen TACS apoptosis kit was purchased from Trevigen
(Gaitherburg, MD). Phalloidin was purchased from Molecular Probes (Eugene,
OR). Blebbistatin, Y-27632, ML-7 and ML-9 were purchased from Calbiochem
(San Diego, CA). latrunculin A was purchased from Molecular Probes. 1-
activating antibody 9EG7 and 1 HUT21 antibodies were purchased from BD
Pharmingen (San Diego, CA). P5D2 1 antibody was obtained from Santa Cruz.
1 clone LM534 was purchased from Chemicon (Temecula, CA). Phospho S19-
MLC antibody was obtained from Abcam (Cambridge, MA) and MLC antibody
from Chemicon (Temecula, CA).
Fig. 9. Model for adhesion-dependent and adhesion-independent
integrin signaling. In model 1, survival signals are generated by both
adhesion and growth factors, as seen in untransformed cells. Model 2
illustrates a possible mechanism of eliminating the requirement for
adhesion by Ras-transformed cells, but signaling events that are still
dependent on myosin II. We propose that Ras-transformed cells can
activate myosin II through MLCK, leading to integrin activation and
associated survival signals.
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Cell culture and drug treatments
MCF-10A cells were maintained in DMEM/F12 (Invitrogen, Carlsbad, CA)
supplemented with 5% donor horse serum, 20 ng/ml EGF (Peprotech, Rocky Hill,
NJ), 10 g/ml insulin (Sigma, St Louis, MO), 1 ng/ml cholera toxin (Sigma), 100
g/ml hydrocortisone (Sigma), 50 U/ml penicillin, and 50 g/ml streptomycin
(Invitrogen). MDCK cells were maintained in DMEM (Invitrogen) supplemented
with 10% fetal calf serum (FCS), 50 U/ml penicillin and 50 g/ml streptomycin.
MCF-10A cells were a generous gift from David Soloman (NIH, Bethesda, MD).
MDCK cells were obtained from ATCC. They were maintained in DMEM
containing 10% fetal bovine serum, 100 g/ml penicillin/streptomycin MDCK Ras
cells were a gift from Linda Van Aelst (Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY). Cells were treated with vehicle alone, Blebbistatin, ML-7, ML-9,
latrunculin A or Y-27632 in media without serum at varying concentrations and time
points before being fixed or prepared for FACS analysis. Untreated cells were also
serum starved for the duration of the inhibitor treatment. Stock solutions of each
agent were made in DMSO (50 M Blebbistatin, 5 mM LA), 50% ethanol (10 mM
ML-7), 70% ethanol (20 mM ML-9) or water (20 mM Y-27632) and were
maintained at –20°C.
Cell extracts and immunoblotting
Cells were washed with ice-cold PBS containing 2 mM sodium orthovanadate
before direct extraction in 2% SDS Laemmli sample buffer. Lysates were clarified
by centrifugation (16,000 g, 15 minutes at 4°C) and protein concentrations were
measured by bicinchoninic acid protein assay (BioRad, Hercules, CA). Equal
amounts of proteins were resolved by SDS-PAGE and transferred to nitrocellulose
membrane (Schleicher & Schuell Bioscience). The membranes were incubated with
primary antibodies overnight at 4°C. After incubation with appropriate HRP-
conjugated secondary antibodies, the immunoreactive bands were detected by
chemiluminescence (NEN) according to the manufacturer’s instructions.
Immunofluorescence
Cells were grown on glass coverslips and treated with indicated drug. The cells were
then fixed in 3% paraformaldehyde for 15 minutes and permeabilized with 0.1%
Triton X-100 in PBS for 10 minutes, and blocked with 5% BSA at room temperature
for 30 minutes. Incubations with primary antibodies against active caspase-3 (1:50),
or anti 1 integrin HUTS21 or P5D2 (1:100) were conducted at room temperature
in 1% BSA for 1 hour. Incubations with secondary antibody and Rhodamine-
phalloidin were conducted in 1% BSA for 45 minutes. Cells were then stained with
Topro-3 1:100 in PBS at room temperature for 15 minutes and coverslips were
mounted using Prolong Antifade (Molecular Probes). Coverslips were examined with
a Zeiss confocal microscope and analyzed by LSM 5 Image Examiner software.
Fluorescence-activated cell sorting
The Trevigen ApoTACS kit was used to stain cells before cell sorting. Cells were
grown on 24-well plates and treated with actin or myosin inhibitors for various times
and concentrations. Cells were trypsinized and media was collected, washed twice
in ice-cold PBS and stained with annexin V FITC and propidium iodide at room
temperature for 15 minutes. Cells were then sorted by a Becton Dickinson LSRII
and analyzed by FACS Diva software.
Anoikis assays
Tissue culture dishes were incubated with 300 mg/ml polyHEMA (Sigma) in 95%
ethanol, and allowed to dry overnight at room temperature. Dishes were rinsed three
times with PBS before use. For anoikis assays, cells were trypsinized, washed twice
with 1 PBS and replated on polyHEMA in DMEM with 1% BSA to prevent
clumping of cells.
Transfection
The non-muscle and smooth muscle MLCK wild-type and dominant-negative
plasmids were a generous gift of Patricia Gallagher (Indiana University,
Indianapolis, IN). Transient transfection of MCF10A cells with these constructs was
performed with Lipofectamine 2000 (Invitrogen). The dominant-negative FADD
vector was kindly provided by Martin Schuler (Johannes Gutenberg University,
Mainz, Germany). pBabe Hygro DN FADD cell lines were produced by transfecting
MCF10A cells with Lipofectamine 2000 and selecting with 750 g/ml G418.
Following selection, cells were pooled, expanded, and tested for the expression of
DN FADD proteins by western blotting, using antibodies for FADD (Calbiochem).
Integrin activation assays
MCF-10A cells were trypsinized and washed twice with 1 PBS with 2% BSA.
Cells were then resuspended with 15 g/l of 1-activating antibody clone 9EG7
and incubated on ice for 30 minutes. Cells were then replated, allowed to spread,
and treated with the appropriate agents.
Statistical analysis
All experiments were performed at least three times. The student’s t-test was used
statistical analysis of data. Values are expressed as mean ± s.e.m. Data were
considered statistically significant at P<0.01.
We wish to thank Patricia Gallagher for providing non-muscle and
smooth muscle MLCK cDNA constructs, and Martin Schuler for
supplying us with pBabe Hygro DN FADD. We also thank Linda Van
Aelst for providing Ras-transformed MDCK cells. Special thanks Yuri
Lazebnik, Senthil Muthuswamy and Geraldine Pawlak for critical
comments and helpful discussions. D.M.H. is supported by a grant
from National Cancer Institute (CA83182).
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